{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
M. K.  Gurjar, Wakharkar, R. D., Singh, A. T., Jaggi, M., Borate, H. B., Shinde, P. D., Verma, R., Rajendran, P., Dutt, S., Singh, G., Sanna, V. K., Singh, M. K., Srivastava, S. K., Mahajan, V. A., Jadhav, V. H., Dutta, K., Krishnan, K., Chaudhary, A., Agarwal, S. K., Mukherjee, R., and Burman, A. C., ?Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents?, Journal of Medicinal Chemistry, vol. 50, no. 8, pp. 1744-1753, 2007.\par \par }